|
Regulations &
Codified CSA > CFR > Section 1304 > Section 1304.26
Sec. 1304.26 Additional recordkeeping
requirements applicable to drug products containing gamma-hydroxybutyric
acid.
In addition to the recordkeeping requirements for
dispensers and researchers provided in Sec.
1304.22, practitioners
dispensing gamma- hydroxybutyric acid that is manufactured or
distributed in accordance with an application under section 505 of the
Federal Food, Drug, and Cosmetic Act must maintain and make available
for inspection and copying by the Attorney General, all of the following
information for each prescription:
(a) Name of the prescribing practitioner.
(b) Prescribing practitioner's Federal and State
registration numbers, with the expiration dates of these
registrations.
(c) Verification that the prescribing
practitioner possesses the appropriate registration to prescribe this
controlled substance.
(d) Patient's name and address.
(e) Patient's insurance provider, if available.
NOTICE: This is an
unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).
|
